微生物鑑定市场- 按产品和服务（仪器[PCR、质谱仪]、消耗品、软体、服务）、方法（表型、基因型）、应用（临床诊断、製药）、最终用途- 全球预测（2024 - 2032）

Microbial Identification Market - By Product and Services (Instrument [PCR, Mass Spectrometer], Consumable, Software, Service), Method (Phenotypic, Genotypic), Application (Clinical Diagnostics, Pharmaceuticals), End-use - Global Forecast (2024 - 2032)

出版日期: 2024年04月25日 | 出版商:

Global Market Insights Inc. | 英文 230 Pages | 商品交期: 2-3个工作天内

价格

简介目录

在协作和伙伴关係的加强以及识别技术的技术进步的推动下，微生物识别市场规模预计从 2024 年到 2032 年将复合年增长率达到 8.8%。研究人员和公司正在结盟，以提高研究能力并扩大应用领域。基因组学和生物资讯学等技术创新也提高了微生物鑑定过程的准确性和速度。

不断取得的进步进一步促进了对新兴病原体的更快反应，并提高了医疗保健、农业和环境监测等各个行业的诊断精确度。例如，2023 年 4 月，JMI 实验室和生物梅里埃合作进行抗菌素抗药性诊断，以利用微生物鑑定的专业知识。此次合作有助于提高诊断能力并应对全球微生物抗药性不断变化的挑战。

整个市场分为产品和服务、方法、应用、最终用途和区域。

在产品和服务方面，在基因组学和光谱学等尖端技术进步的推动下，微生物鑑定市场的仪器部分预计将在 2024 年至 2032 年期间实现显着的复合年增长率。仪器有助于提高从医疗保健到农业等各个领域鑑定微生物的准确性和效率。人工智慧和自动化的整合以简化流程和提高诊断速度等发展也使得能够更快地回应新兴病原体并促进个人化治疗策略，从而促进该细分市场的成长。

从应用来看，製药领域的微生物鑑定产业预计将在 2024 年至 2032 年期间成长。分子生物学技术和质谱分析正在提高药物开发和製造过程中微生物鑑定的准确性和速度。製药公司也正在优化生物资讯学和资料分析方面的品质控制措施和监管合规性，以主动管理微生物风险。

从地区来看，在人们对加强食品安全和扩大医疗基础设施的日益关注的推动下，亚太地区微生物鑑定市场规模预计将在 2024 年至 2032 年间呈现强劲增长。 PCR和MALDI-TOF等先进技术被广泛采用，以确保食品和临床应用中微生物的精确鑑定。对医疗保健设施的投资正在加强提供更广泛的先进诊断工具和加强区域医疗保健系统的努力，进一步推动亚太地区的产业扩张。

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 荷兰
- 欧洲其他地区
亚太地区
- 日本
- 中国
- 印度
- 澳洲
- 韩国
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地区
中东和非洲
- 沙乌地阿拉伯
- 南非
- 阿联酋
- 中东和非洲其他地区

第 10 章：公司简介

Avantor, Inc.
bioMérieux SA
Becton, Dickinson and Company
Bruker Corporation
Beckman Coulter, Inc.
Biolog, Inc.
Charles River Laboratories International, Inc.
Eurofins Scientific
Merck KGaA
Qiagen N.V.
Shimadzu Corporation
Thermo Fisher Scientific Inc.
Wickham Micro Limited

简介目录

Product Code: 9221

Microbial Identification Market size is projected to record 8.8% CAGR from 2024 to 2032, driven by increasing collaboration and partnerships alongside technological advancements in identification techniques. Researchers and companies are forging alliances to enhance research capabilities and expand application areas. Technological innovations, such as genomics and bioinformatics are also improving the accuracy and speed of microbial identification processes.

Growing advancements are further facilitating quicker responses to emerging pathogens and improving diagnostic precision in various industries, including healthcare, agriculture, and environmental monitoring. For instance, in April 2023, JMI Laboratories and bioMerieux partnered for antimicrobial resistance diagnostics for leveraging expertise in microbial identification. This collaboration helped in advancing diagnostic capabilities and addressing evolving challenges in microbial resistance globally.

The overall market is segregated into product and services, method, application, end-use, and region.

In terms of product and services, the instruments segment in the microbial identification market is expected to record significant CAGR from 2024 to 2032, propelled by advances in cutting-edge technologies like genomics and spectroscopy. Instruments help in enhancing accuracy and efficiency in identifying microorganisms across various sectors from healthcare to agriculture. Developments, such as integration of AI and automation to streamline processes and improve diagnostic speed are also enabling quicker responses to the emerging pathogens and facilitating personalized treatment strategies, adding to the segment growth.

By application, the microbial identification industry from the pharmaceuticals segment is projected to rise from 2024 to 2032. This is driven hefty investments by pharmaceutical companies on advanced microbial identification technologies to ensure product safety and efficacy. Molecular biology techniques and mass spectrometry are improving the accuracy and speed of microbial identification in drug development and manufacturing processes. Pharmaceuticals are also optimizing quality control measures and regulatory compliance in bioinformatics and data analytics for proactive management of microbial risks.

Regionally, the Asia Pacific microbial identification market size is projected to exhibit robust growth between 2024 and 2032, fueled by increasing attention on enhancing food safety and expanding healthcare infrastructure. Advanced technologies, such as PCR and MALDI-TOF are widely adopted to ensure precise microbial identification in both food and clinical applications. Investments in healthcare facilities are bolstering the efforts for providing broader access to advanced diagnostic tools and strengthening regional healthcare systems, further driving the industry expansion in APAC.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing prevalence of infectious diseases
  - 3.2.1.2 Rising technological advancements
  - 3.2.1.3 Increasing awareness about food safety
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High cost of automated microbial identification systems
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Porter's analysis
3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Product and Services, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Instruments
- 5.2.1 Mass spectrometers
- 5.2.2 PCR systems
- 5.2.3 Microarrays
- 5.2.4 Other instruments
5.3 Consumables
- 5.3.1 Reagents and kits
- 5.3.2 Plates and media
5.4 Software
5.5 Services

Chapter 6 Market Estimates and Forecast, By Method, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Phenotypic methods
6.3 Genotypic methods
6.4 Proteotypic methods

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Clinical diagnostics
7.3 Pharmaceuticals
7.4 Cosmetic and personal care product testing
7.5 Food and beverage testing
7.6 Environmental application
7.7 Other applications

Chapter 8 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 Pharmaceutical and biotechnology companies
8.3 Hospitals and diagnostic laboratories
8.4 Food testing laboratories
8.5 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

9.1 Key trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Netherlands
- 9.3.7 Rest of Europe
9.4 Asia Pacific
- 9.4.1 Japan
- 9.4.2 China
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.5.4 Rest of Latin America
9.6 Middle East and Africa
- 9.6.1 Saudi Arabia
- 9.6.2 South Africa
- 9.6.3 UAE
- 9.6.4 Rest of Middle East and Africa